Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs PFIZER - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES PFIZER DIVIS LABORATORIES/
PFIZER
 
P/E (TTM) x 66.0 38.2 172.7% View Chart
P/BV x 7.1 6.0 119.5% View Chart
Dividend Yield % 0.9 1.7 52.3%  

Financials

 DIVIS LABORATORIES   PFIZER
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-23
PFIZER
Mar-23
DIVIS LABORATORIES/
PFIZER
5-Yr Chart
Click to enlarge
High Rs4,6414,662 99.5%   
Low Rs2,7303,407 80.1%   
Sales per share (Unadj.) Rs292.6530.0 55.2%  
Earnings per share (Unadj.) Rs68.7136.4 50.4%  
Cash flow per share (Unadj.) Rs81.6159.4 51.2%  
Dividends per share (Unadj.) Rs30.0070.00 42.9%  
Avg Dividend yield %0.81.7 46.9%  
Book value per share (Unadj.) Rs480.9701.0 68.6%  
Shares outstanding (eoy) m265.4745.75 580.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x12.67.6 165.5%   
Avg P/E ratio x53.729.6 181.4%  
P/CF ratio (eoy) x45.225.3 178.5%  
Price / Book Value ratio x7.75.8 133.2%  
Dividend payout %43.751.3 85.1%   
Avg Mkt Cap Rs m978,378184,576 530.1%   
No. of employees `000NANA-   
Total wages/salary Rs m9,7503,317 294.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m77,67524,248 320.3%  
Other income Rs m3,4471,011 341.1%   
Total revenues Rs m81,12225,258 321.2%   
Gross profit Rs m23,6918,420 281.4%  
Depreciation Rs m3,4321,055 325.3%   
Interest Rs m20135 14.5%   
Profit before tax Rs m23,6868,240 287.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,4532,001 272.5%   
Profit after tax Rs m18,2346,239 292.2%  
Gross profit margin %30.534.7 87.8%  
Effective tax rate %23.024.3 94.8%   
Net profit margin %23.525.7 91.2%  
BALANCE SHEET DATA
Current assets Rs m97,43724,933 390.8%   
Current liabilities Rs m15,3316,574 233.2%   
Net working cap to sales %105.775.7 139.6%  
Current ratio x6.43.8 167.6%  
Inventory Days Days893 9.0%  
Debtors Days Days8422 36,879.2%  
Net fixed assets Rs m51,12813,780 371.0%   
Share capital Rs m531458 116.0%   
"Free" reserves Rs m127,14031,616 402.1%   
Net worth Rs m127,67132,073 398.1%   
Long term debt Rs m00-   
Total assets Rs m148,56539,031 380.6%  
Interest coverage x1,209.562.1 1,946.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.50.6 84.2%   
Return on assets %12.316.3 75.2%  
Return on equity %14.319.5 73.4%  
Return on capital %18.626.1 71.1%  
Exports to sales %85.72.8 3,019.9%   
Imports to sales %19.80 57,149.2%   
Exports (fob) Rs m66,537688 9,673.9%   
Imports (cif) Rs m15,3788 183,072.6%   
Fx inflow Rs m66,537688 9,673.9%   
Fx outflow Rs m15,7158 187,079.8%   
Net fx Rs m50,822679 7,480.4%   
CASH FLOW
From Operations Rs m24,5973,557 691.6%  
From Investments Rs m-27,076-361 7,510.7%  
From Financial Activity Rs m-7,972-3,458 230.5%  
Net Cashflow Rs m-10,451-262 3,994.9%  

Share Holding

Indian Promoters % 51.9 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 36.7 18.2 202.1%  
FIIs % 14.9 3.0 490.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 36.1 133.3%  
Shareholders   354,482 112,456 315.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Divis Laboratories vs Pfizer

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Divis Laboratories vs Pfizer Share Price Performance

Period Divis Laboratories Pfizer S&P BSE HEALTHCARE
1-Day 2.14% -4.80% 1.18%
1-Month -2.15% -8.24% -0.75%
1-Year 22.51% 21.78% 61.82%
3-Year CAGR -1.38% -2.07% 18.16%
5-Year CAGR 15.77% 4.95% 19.79%

* Compound Annual Growth Rate

Here are more details on the Divis Laboratories share price and the Pfizer share price.

Moving on to shareholding structures...

The promoters of Divis Laboratories hold a 51.9% stake in the company. In case of Pfizer the stake stands at 63.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Divis Laboratories and the shareholding pattern of Pfizer.

Finally, a word on dividends...

In the most recent financial year, Divis Laboratories paid a dividend of Rs 30.0 per share. This amounted to a Dividend Payout ratio of 43.7%.

Pfizer paid Rs 70.0, and its dividend payout ratio stood at 51.3%.

You may visit here to review the dividend history of Divis Laboratories, and the dividend history of Pfizer.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.